Variant sublines of the human B-lymphoma cells Namalwa are at different stages of differentiation.
Variant sublines of the Burkitt's lymphoma cell line Namalwa, previously shown to differ in MHC class II antigen and immunoglobulin expression, have been tested with monoclonal antibodies defining B-cell specific clusters of differentiation (CD). The Namalwa sublines express antigens recognized by the CD antibodies in patterns that indicate that the cells are arrested at different stages of differentiation.
D000951:Antigens, Neoplasm / Q000032:analysis*; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology*; D002051:Burkitt Lymphoma / Q000276:immunology / Q000473:pathology*; D002454:Cell Differentiation; D002460:Cell Line; D006133:Growth Substances / Q000032:analysis*; D006801:Humans; D015847:Interleukin-4; D008222:Lymphokines / Q000032:analysis*
D000951:Antigens, Neoplasm; D006133:Growth Substances; D008222:Lymphokines; D015847:Interleukin-4